1. L -Carnitine-Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme.
- Author
-
Fink MA, Paland H, Herzog S, Grube M, Vogelgesang S, Weitmann K, Bialke A, Hoffmann W, Rauch BH, Schroeder HWS, and Bien-Möller S
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Apoptosis, Biomarkers, Tumor genetics, Case-Control Studies, Cell Movement, Child, Child, Preschool, Female, Follow-Up Studies, Gene Expression Regulation, Neoplastic, Glioblastoma metabolism, Glioblastoma pathology, Glioblastoma surgery, Humans, Infant, Male, Mice, Mice, Inbred C57BL, Middle Aged, Neoplasm Recurrence, Local metabolism, Neoplasm Recurrence, Local pathology, Neoplasm Recurrence, Local surgery, Prognosis, Solute Carrier Family 22 Member 5 genetics, Survival Rate, Tumor Cells, Cultured, Xenograft Model Antitumor Assays, Young Adult, Biomarkers, Tumor metabolism, Carnitine metabolism, Cell Proliferation, Cytoprotection, Glioblastoma mortality, Neoplasm Recurrence, Local mortality, Solute Carrier Family 22 Member 5 metabolism
- Abstract
Purpose: Apoptotic dysregulation, redox adaptive mechanisms, and resilience to hypoxia are major causes of glioblastoma (GBM) resistance to therapy. Commonly known as crucial factors in energy metabolism, OCTN2 (SLC22A5) and its substrate L -carnitine (LC) are increasingly recognized as actors in cytoprotection. This study provides a comprehensive expression and survival analysis of the OCTN2/LC system in GBM and clarifies the system's impact on GBM progression., Experimental Design: OCTN2 expression and LC content were measured in 121 resected human GBM specimens and 10 healthy brain samples and analyzed for prognostic significance. Depending on LC administration, the effects of hypoxic, metabolic, and cytotoxic stress on survival and migration of LN18 GBM cells were further studied in vitro . Finally, an orthotopic mouse model was employed to investigate inhibition of the OCTN2/LC system on in vivo GBM growth., Results: Compared with healthy brain, OCTN2 expression was increased in primary and even more so in recurrent GBM on mRNA and protein level. High OCTN2 expression was associated with a poor overall patient survival; the unadjusted HR for death was 2.7 (95% CI, 1.47-4.91; P < 0.001). LC administration to GBM cells increased their tolerance toward cytotoxicity, whereas siRNA-mediated OCTN2 silencing led to a loss of tumor cell viability. In line herewith, OCTN2/LC inhibition by meldonium resulted in reduced tumor growth in an orthotopic GBM mouse model., Conclusions: Our data indicate a potential role of the OCTN2/LC system in GBM progression and resistance to therapy, and suggests OCTN2 as a prognostic marker in patients with primary GBM., (©2019 American Association for Cancer Research.)
- Published
- 2019
- Full Text
- View/download PDF